Search Medical Condition
Please enter condition
Please choose location

Osteoporosis Clinical Trials

A listing of Osteoporosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (80) clinical trials

Osteoporosis is a disease in which bones become thin and weak causing them to break more easily. It is often called a "silent disease" because there are no symptoms; you can't feel your bones becoming weak. You may be at risk if you… Are over 50 years old Are postmenopausal ...

Phase N/A

Currently looking for women who: Are 55 years or older and prescribed a daily or weekly medication for osteoporosis Have stopped using osteoporosis medication, or have not taken osteoporosis medication as prescribed by their doctor Are willing to participate in a 12-month study Your participation in a study could help ...

Phase

We are looking for postmenopausal women, 45 years of age or older, who have been diagnosed with osteoporosis to participate in a clinical research study. This study is currently enrolling, and will evaluate the safety and effectiveness of an investigational medication in reducing fractures due to osteoporosis. There is no ...

Phase N/A

Currently we have the following studies: Birth Control/ Contraceptive Vaginal Atrophy Pain During Intercourse Dysplasia Endometriosis Pap Smear Mammogram Bone Density Osteoporosis Nocturia Uterine Fibroids Uterine Bleeding Post Menopausal Studies HPV STD Hot Flashes

Phase N/A

Postmenopausal Osteoporosis is the medical term used for the disease that weakens bones in women, increasing the risk of sudden and unexpected fractures. Literally meaning "porous bone," osteoporosis results in an increased loss of bone mass and strength. The disease often progresses without any symptoms or pain. Many times, osteoporosis ...

Phase N/A

This clinical trial is provided by Antidote. The research study is evaluating a new medicine for type 2 diabetes for patients whose diabetes is not well controlled with their current therapy. The study medicine is being evaluated to see if it can help in the management of type 2 diabetes ...

Phase

The purpose of this study is to provide 24 - 52 week efficacy, safety and tolerability data, as well as up to 3.5-year efficacy, safety and tolerability data in subjects with active Psoriatic Arthritis despite current or previous nonsteroidal anti-inflammatory drug (NSAID), disease-modifying antirheumatic drug (DMARD) therapy and/or previous anti-tumor ...

Phase

FINCH 1 is enrolling RA patients who have taken methotrexate (also known as MTX, TREXALL, or RASUVO) but have not yet tried a biologic treatment. Filgotinib (study drug) is an oral medication designed to reduce joint inflammation.

Phase